Elan Drug Technologies

Delivering the Future

Celebrating 40 years

Thursday 9th 2010f September 2010

Navigation

You are here: Products & Clients » Case Studies

Products & Clients

Case Studies

NanoCrystal® Technology Case Studies:

Rapamune®

Differentiation through enhanced patient acceptability - Rapamune^® Oral Tablet formation. Improving Patient Compliance and Convenience with NanoCrystal^® Technology

» Read this case study

Megace® ES

Enhanced patient acceptability - creating a branded opportunity

» Read this case study

Oral Controlled Release Case Studies:

Verelan® PM

Once daily, night-time dosed, anti-hypertensive to minimise risk of early morning cardiovascular events
» Read this case study

Avinza®

Once Daily, Novel Dual Release Morphine Sulphate using Elan Drug Technologies' proprietary SODAS^® Technology

» Read this case study

Sign-up for updates

Click here to sign up for news and updates.

Elan Corporation, plc. Registered Office: Treasury Building, Lower Grand Canal Street, Dublin 2, Ireland. Registered in Ireland, Number 30356.